A genome-wide association study for pancreatic cancer has, for the first time, identified regions on three chromosomes that may harbor risk factors for the ...
Sales of Tarceva (erlotinib), for advanced lung and pancreatic cancer, increased 10% to 1.3 billion Swiss francs. Demand is being driven by increased use of ...